AstraZeneca Stomach Cancer Drug Trial: Sone-Ve Versus the Rival Claudin 18.2 ADC
How the AstraZeneca stomach cancer drug trial compares with Takeda’s rival claudin 18.2 ADC, plus regulatory status and corrected numbers.
AstraZeneca Stomach Cancer Drug Trial: Sone-Ve Versus the Rival Claudin 18.2 ADC
How the AstraZeneca stomach cancer drug trial compares with Takeda’s rival claudin 18.2 ADC, plus regulatory status and corrected numbers.
Takeda Gastric Cancer Drug Trial: Filing Plans, Partner and Pipeline Impact
After the Takeda gastric cancer drug trial: planned Japan filing, China priority review, the Innovent partnership and what is still unknown.
Roche Divarasib Phase 3 Trial: What It Means for Lumakras and Krazati
The Roche divarasib Phase 3 trial beat sotorasib and adagrasib on survival. What it means for competitors, analysts and the untreated-patient market.
Paras Healthcare IPO Subscription: What Investors Are Buying in the Hospital Group
The Paras Healthcare IPO subscription closed at 2.34 times. A look at the hospital business, the profit turnaround and the offer structure.
Talkiatry Therapy Services Nationwide: What Patients Should Know
What Talkiatry therapy services nationwide mean for patients on psychiatric medication: coverage, claims, and the questions still unanswered.
Healthcare AI Adoption Survey 2026: A Hospital Leader Checklist
What the healthcare AI adoption survey 2026 means for hospital leaders: 91% want AI training, but a quarter lack clear governance. A checklist.
FDA Prescription Drug Software Guidance: What Sponsors and App Developers Must Do
The FDA prescription drug software guidance gives sponsors a decision tree for apps and labeling. A plain-language walk-through and what is unclear.
Redesign Health ARC Global Merger Brings an AVIA Acquisition: What the Terms Show
The Redesign Health ARC Global merger comes with a planned AVIA acquisition. What is disclosed on terms, leadership and valuation, and what is not.
BD Alaris Infusion Set FDA Alert Puts Kit Supply Chains Under the Spotlight
The BD Alaris infusion set FDA alert reaches hospitals through Cardinal Health Presource kits. What procurement and supply teams need to know.
